Milbank Memorial Fund

Context: Community health worker (CHW) programs represent a key strategy for addressing social and structural drivers of health and have the… More

Context: Evidence suggests Medicaid expansion has improved cardiovascular disease (CVD) outcomes, especially among those of lower socioeconomic… More

This Perspective examines the role of Medicaid in the innovation of substance use disorder (SUD) treatment. In 2023, an estimated 49 million Americans met criteria for an SUD and more than 100,000 people died of a drug overdose. Compared with the general population, people with SUD experience worse self-rated health, a higher burden of other chronic diseases, and more hospital care. More

This issue of the Quarterly opens with a thoughtful Perspective on equity in evidence-informed decision making, and is followed by original scholarship on an array of policy topics, including: insurance to improve patient access to cell and gene therapy; essential medicines in the World Health Organization’s Model Lists; access to mental health treatment; principles for embedding health equity language in policy research and practice; comprehensiveness in primary care; and whole person health assessments. More

The World Health Organization (WHO) Model Lists of Essential Medicines (EML) aims to help countries select medicines based on the priority needs of their populations. However, rapid evolution within the pharmaceutical sector toward complex, high-priced medicines has challenged WHO decision making, leading to inconsistent decisions. The purpose of this paper is to investigate how political factors impact the WHO EML. More

Over the past 50 years, population health researchers have made significant progress in clarifying the empirical and theoretical relationships between socioeconomic conditions and health disparities particularly for social constructs such as race and ethnicity.  More